Hana Pharm (293480) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, Hana Pharm (293480) reported revenue of 239.5 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
2025239.5 billion KRW25.8 billion KRW8.8 billion KRW[source]
2024225.3 billion KRW25.2 billion KRW21.3 billion KRW[source]
2023224.5 billion KRW27.0 billion KRW22.3 billion KRW[source]
2022210.8 billion KRW31.2 billion KRW24.3 billion KRW[source]
2021196.4 billion KRW36.0 billion KRW28.0 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
2025418.1 billion KRW104.7 billion KRW313.4 billion KRW[source]
2024382.0 billion KRW72.8 billion KRW309.2 billion KRW[source]
2023348.4 billion KRW70.4 billion KRW278.0 billion KRW[source]
2022346.0 billion KRW77.6 billion KRW268.4 billion KRW[source]
2021303.5 billion KRW51.6 billion KRW251.9 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice